HT
DFTX

HAP Trading’s Definium Therapeutics DFTX Stock Holding History

HAP Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,953
Closed -$75K – 2209
2022
Q1 		$75K Buy
13,953
+12,540
+887% +$218K ﹤0.01% 1133
2021
Q4 		$43K Sell
1,413
-420
-23% -$13.4K ﹤0.01% 1544
2021
Q3 		$34K Sell
1,833
-374
-17% -$16.2K ﹤0.01% 1638
2021
Q2 		$34K Buy
+2,207
New +$116K ﹤0.01% 1621

Other funds holding DFTX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's DFTX Position: Q3 2021 in Review

HAP Trading sold out of Definium Therapeutics (DFTX) in Q3 2021, closing a stake of 4,537 shares — an estimated $196K sold.

HAP Trading first reported a position in DFTX in Q2 2021 and held it in 1 quarter. The position peaked at $235K in Q2 2021. 174 funds tracked by Wall St. Rank hold DFTX as of Q3 2021.

  • HAP Trading reported no remaining Definium Therapeutics position as of Q3 2021 after selling out during the quarter.
  • HAP Trading sold 4,537 Definium Therapeutics shares in Q3 2021, an estimated $196K.
  • HAP Trading first reported a position in Definium Therapeutics in Q2 2021 and held it in 1 quarter.
  • HAP Trading's Definium Therapeutics position peaked at $235K in Q2 2021.
  • 174 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2021.

Based on HAP Trading's 13F filing for Q3 2021, filed 10 Nov 2021.